According to TipRanks.com, McCarthy has 0 stars on 0-5 stars ranking scale with an average return of -14.0% and a 33.4% success rate. McCarthy covers the Healthcare sector, focusing on stocks such as ...
Stocktwits on MSN
Biohaven’s phase II depression trial falls short, but analysts downplay impact – Wall Street looks ahead to epilepsy data
Analyst Myles Minter noted that the company’s pivotal Phase III study of BHV-7000 in focal-onset epilepsy in the first half ...
Biohaven's Phase 2 study with BHV-7000 in MDD did not meet its primary endpoint of reducing depressive symptoms in comparison ...
Scientists in China have constructed and tested a device that uses redox couples paired with a single triple-junction amorphous-silicon photoelectrode. When tested under a xenon lamp simulating one ...
This trend isn’t new, but it has been supercharged by social media and will undoubtedly continue to grow in 2026. Resist it ...
Blinding headlights pose a serious risk to motorists and pedestrians at night. Technology to reduce glare and improve ...
William Blair has hand-picked its top five stock recommendations for 2026, selections that include three clinical-stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback